Hepatitis E: An emerging infection in high income countries

Journal of Clinical Virology

Volumn 59, Issue 2, 2014, Pages 81-88

  Arends, J E ^a,g   Ghisetti, V ^b,g   Irving, W ^c,g   Dalton, H R ^d   Izopet, J ^e   Hoepelman, A I M ^a,g   Salmon, D ^f,g  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b AMEDEO DI SAVOIA HOSPITAL   (Italy)

^c QUEEN S MEDICAL CENTRE   (United Kingdom)

^d ROYAL CORNWALL HOSPITALS NHS TRUST   (United Kingdom)

^e University of Toulouse III   (France)

^f Institut Cochin   (France)

^g European Society of Clinical Microbiology and Infectious Diseases (ESCMID)   (Switzerland)

Author keywords

Genotype 3; Hepatitis E; Ribavirin, Autochthonous transmission

Indexed keywords

RIBAVIRIN;

ACUTE HEPATITIS; ANTIGENIC VARIATION; BACULOVIRUS; CELL SURVIVAL; CHRONIC LIVER DISEASE; DISEASE TRANSMISSION; ENDOPLASMIC RETICULUM; ESCHERICHIA COLI; GENETIC HETEROGENEITY; GENETIC VARIABILITY; GENOME ANALYSIS; HEPATITIS E; HEPATITIS E VIRUS; HEPATITIS E VIRUS GENOTYPE 3; HEPATITIS E VIRUS GENOTYPE 4; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOCOMPROMISED PATIENT; NONHUMAN; OPEN READING FRAME; PRIORITY JOURNAL; PROTEIN PROCESSING; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; REVIEW; SEROLOGY; SEROPREVALENCE; VACCINATION; VIROLOGY; VIRUS CAPSID; VIRUS GENOME; VIRUS MORPHOLOGY; VIRUS NEUTRALIZATION; VIRUS REPLICATION;

GENOTYPE 3; HEPATITIS E; RIBAVIRIN, AUTOCHTHONOUS TRANSMISSION;

COMMUNICABLE DISEASES, EMERGING; DEVELOPED COUNTRIES; HEPATITIS E; HEPATITIS E VIRUS; HUMANS; IMMUNOASSAY; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; VIROLOGY;

EID: 84892954407     PISSN: 13866532     EISSN: 18735967     Source Type: Journal    
DOI: 10.1016/j.jcv.2013.11.013     Document Type: Review

References (114)

1. Tam A.W., Smith M.M., Guerra M.E., Huang C.C., Bradley D.W., Fry K.E., et al. Hepatitis E virus (HEV): molecular cloning and sequencing of the full-length viral genome. Virology 1991, 185:120-131.
2. Dalton H.R., Hunter J.G., Bendall R.P., Hepatitis E. Curr Opin Infect Dis 2013, 26:471-478.
3. Yamashita T., Mori Y., Miyazaki N., Cheng R.H., Yoshimura M., Unno H., et al. Biological and immunological characteristics of hepatitis E virus-like particles based on the crystal structure. Proc Natl Acad Sci U S A 2009, 106:12986-12991.
4. Ahmad I., Holla R.P., Jameel S. Molecular virology of hepatitis E virus. Virus Res 2011, 161:47-58.
5. Fan J. Open reading frame structure analysis as a novel genotyping tool for hepatitis E virus and the subsequent discovery of an inter-genotype recombinant. J Gen Virol 2009, 90:1353-1358.
6. Korkaya H., Jameel S., Gupta D., Tyagi S., Kumar R., Zafrullah M., et al. The ORF3 protein of hepatitis E virus binds to Src homology 3 domains and activates MAPK. J Biol Chem 2001, 276:42389-42400.
7. Aye T.T., Uchida T., Ma X., Iida F., Shikata T., Zhuang H., et al. Sequence comparison of the capsid region of hepatitis E viruses isolated from Myanmar and China. Microbiol Immunol 1992, 36:615-621.
8. Okamoto H. Genetic variability and evolution of hepatitis E virus. Virus Res 2007, 127:216-228.
9. Wedemeyer H., Pischke S., Manns M.P. Pathogenesis and treatment of hepatitis E virus infection. Gastroenterology 2012, 142:1388-1397.
10. Caron M., Enouf V., Than S.C., Dellamonica L., Buisson Y., Nicand E. Identification of genotype 1 hepatitis E virus in samples from swine in Cambodia. J Clin Microbiol 2006, 44:3440-3442.
11. Geng J., Wang L., Wang X., Fu H., Bu Q., Liu P., et al. Potential risk of zoonotic transmission from young swine to human: seroepidemiological and genetic characterization of hepatitis E virus in human and various animals in Beijing, China. J Viral Hepat 2011, 18:e583-e590.
12. Kamar N., Bendall R., Legrand-Abravanel F., Xia N.S., Ijaz S., Izopet J., et al. Hepatitis E. Lancet 2012, 379(9835):2477-2488.
13. Feagins A.R., Opriessnig T., Guenette D.K., Halbur P.G., Meng X.J. Detection and characterization of infectious hepatitis E virus from commercial pig livers sold in local grocery stores in the USA. J Gen Virol 2007, 88:912-917.
14. Bouwknegt M., Lodder-Verschoor F., van der Poel W.H., Rutjes S.A., de Roda Husman A.M. Hepatitis E virus RNA in commercial porcine livers in the Netherlands. J Food Prot 2007, 70:2889-2895.
15. Berto A., Backer J.A., Mesquita J.R., Nascimento M.S., Banks M., Martelli F., et al. Prevalence and transmission of hepatitis E virus in domestic swine populations in different European countries. BMC Res Notes 2012, 5:190-195. 10.1186/1756-0500-5-190.
16. Haqshenas G., Shivaprasad H.L., Woolcock P.R., Read D.H., Meng X.J. Genetic identification and characterization of a novel virus related to human hepatitis E virus from chickens with hepatitis-splenomegaly syndrome in the United States. J Gen Virol 2001, 82:2449-2462.
17. Payne C.J., Ellis T.M., Plant S.L., Gregory A.R., Wilcox G.E. Sequence data suggests big liver and spleen disease virus (BLSV) is genetically related to hepatitis E virus. Vet Microbiol 1999, 68:119-125.
18. Guo H., Zhou E.M., Sun Z.F., Meng X.J., Halbur P.G. Identification of B-cell epitopes in the capsid protein of avian hepatitis E virus (avian HEV) that are common to human and swine HEVs or unique to avian HEV. J Gen Virol 2006, 87:217-223.
19. Okamoto H. Hepatitis E virus cell culture models. Virus Res 2011, 161:65-77.
20. Dalton H.R., Bendall R.P., Keane F.E., Tedder R.S., Ijaz S. Persistent carriage of hepatitis E virus in patients with HIV infection. N Engl J Med 2009, 361:1025-1027.
21. Shukla P., Nguyen H.T., Torian U., Engle R.E., Faulk K., Dalton H.R., et al. Cross-species infections of cultured cells by hepatitis E virus and discovery of an infectious virus-host recombinant. Proc Natl Acad Sci U S A 2011, 108:2438-2443.
22. Varma S.P., Kumar A., Kapur N., Durgapal H., Acharya S.K., Panda S.K. Hepatitis E virus replication involves alternating negative- and positive-sense RNA synthesis. J Gen Virol 2011, 92:572-581.
23. Baylis S.A., Hanschmann K.M., Blumel J., Nubling C.M. Standardization of hepatitis E virus (HEV) nucleic acid amplification technique-based assays: an initial study to evaluate a panel of HEV strains and investigate laboratory performance. J Clin Microbiol 2011, 49:1234-1239.
24. Drobeniuc J., Meng J., Reuter G., Greene-Montfort T., Khudyakova N., Dimitrova Z., et al. Serologic assays specific to immunoglobulin M antibodies against hepatitis E virus: pangenotypic evaluation of performances. Clin Infect Dis 2010, 51:e24-e27.
25. Khudyakov Y., Kamili S. Serological diagnostics of hepatitis E virus infection. Virus Res 2011, 161:84-92.
26. Legrand-Abravanel F., Thevenet I., Mansuy J.M., Saune K., Vischi F., Peron J.M., et al. Good performance of immunoglobulin M assays in diagnosing genotype 3 hepatitis E virus infections. Clin Vaccine Immunol 2009, 16:772-774.
27. Mast E.E., Alter M.J., Holland P.V., Purcell R.H. Evaluation of assays for antibody to hepatitis E virus by a serum panel, Hepatitis E Virus Antibody Serum Panel Evaluation Group. Hepatology 1998, 27:857-861.
28. Mushahwar I.K. Hepatitis E virus: molecular virology, clinical features, diagnosis, transmission, epidemiology, and prevention. J Med Virol 2008, 80:646-658.
29. Li S., Tang X., Seetharaman J., Yang C., Gu Y., Zhang J., et al. Dimerization of hepatitis E virus capsid protein E2s domain is essential for virus-host interaction. PLoS Pathog 2009, 5:e1000537.
30. Sarin S.K., Kumar M. Hepatitis E. Zakim & Boyer's hepatology: a textbook of liver disease 2006, 693-724. 5th ed.
31. Kamar N., Selves J., Mansuy J.M., Ouezzani L., Peron J.M., Guitard J., et al. Hepatitis E virus and chronic hepatitis in organ-transplant recipients. N Engl J Med 2008, 358:811-817.
32. Baylis S.A., Mizusawa S., Okada Y., Hanschmann K.-M.O. Collaborative study to establish as World Health Organization international standard for hepatitis E virus RNA for nucleic acid amplification technology (NAT)-based assays. WHO/BS/2011 2175 2011, http://www.who.int/biologicals/expert_committee/BS2011.2175HEV_NAT.pdf.
33. Bader T.F., Krawczynski K., Polish L.B., Favorov M.O. Hepatitis E in a U.S. traveler to Mexico. N Engl J Med 1991, 325:1659.
34. Teshale E.H., Hu D.J., Holmberg S.D. The two faces of hepatitis E virus. Clin Infect Dis 2010, 51:328-334.
35. Dalton H.R., Bendall R., Ijaz S., Banks M. Hepatitis E: an emerging infection in developed countries. Lancet Infect Dis 2008, 8:698-709.
36. Herremans M., Vennema H., Bakker J., van d V., Duizer E., Benne C.A., et al. Swine-like hepatitis E viruses are a cause of unexplained hepatitis in the Netherlands. J Viral Hepat 2007, 14:140-146.
37. Berto A., Martelli F., Grierson S., Banks M. Hepatitis E virus in pork food chain, United Kingdom, 2009-2010. Emerg Infect Dis 2012, 18:1358-1360.
38. Colson P., Borentain P., Queyriaux B., Kaba M., Moal V., Gallian P., et al. Pig liver sausage as a source of hepatitis E virus transmission to humans. J Infect Dis 2010, 202:825-834.
39. Crossan C, Bakker PJ, Takeuchi Y, Dalton HR, Scobie L. Identification of hepatitis E virus genotype-3 in shellfish in the United Kingdom. 2012; 18(12): 2085-2087.
40. Lack J.B., Volk K., Van Den Bussche R.A. Hepatitis E virus genotype 3 in wild rats, United States. Emerg Infect Dis 2012, 18:1268-1273.
41. Izopet J., Dubois M., Bertagnoli S., Lhomme S., Marchandeau S., Boucher S., et al. Hepatitis E virus strains in rabbits and evidence of a closely related strain in humans, France. Emerg Infect Dis 2012, 18:1274-1281.
42. Colson P., Romanet P., Moal V., Borentain P., Purgus R., Benezech A., et al. Autochthonous infections with hepatitis E virus genotype 4, France. Emerg Infect Dis 2012, 18:1361-1364.
43. Pischke S., Wedemeyer H. Hepatitis E virus infection: multiple faces of an underestimated problem. J Hepatol 2012, 10.
44. Choi J.Y., Lee J.M., Jo Y.W., Min H.J., Kim H.J., Jung W.T., et al. Genotype-4 hepatitis E in a human after ingesting roe deer meat in South Korea. Clin Mol Hepatol 2013, 19:309-314.
45. Stefanidis I., Zervou E.K., Rizos C., Syrganis C., Patsidis E., Kyriakopoulos G., et al. Hepatitis E virus antibodies in hemodialysis patients: an epidemiological survey in central Greece. Int J Artif Organs 2004, 27:842-847.
46. Zaaijer H.L., Kok M., Lelie P.N., Timmerman R.J., Chau K., van der Pal H.J. Hepatitis E in the Netherlands: imported and endemic. Lancet 1993, 341:826.
47. Zanetti A.R., Dawson G.J. Hepatitis type E in Italy: a seroepidemiological survey, Study Group of Hepatitis E. J Med Virol 1994, 42:318-320.
48. Kuniholm M.H., Purcell R.H., McQuillan G.M., Engle R.E., Wasley A., Nelson K.E. Epidemiology of hepatitis E virus in the United States: results from the Third National Health and Nutrition Examination Survey, 1988-1994. J Infect Dis 2009, 200:48-56.
49. Drobeniuc J., Favorov M.O., Shapiro C.N., Bell B.P., Mast E.E., Dadu A., et al. Hepatitis E virus antibody prevalence among persons who work with swine. J Infect Dis 2001, 184:1594-1597.
50. Legrand-Abravanel F., Kamar N., Sandres-Saune K., Lhomme S., Mansuy J.M., Muscari F., et al. Hepatitis E virus infection without reactivation in solid-organ transplant recipients, France. Emerg Infect Dis 2011, 17:30-37.
51. Mansuy J.M., Bendall R., Legrand-Abravanel F., Saune K., Miedouge M., Ellis V., et al. Hepatitis E virus antibodies in blood donors, France. Emerg Infect Dis 2011, 17:2309-2312.
52. Slot E., Hogema B.M., Riezebos-Brilman A., Kok T.M., Molier M., Zaaijer H.L. Silent hepatitis E virus infection in Dutch blood donors, 2011 to 2012. Eurosurveillance 2013, 18:20550.
53. Baylis S.A., Gartner T., Nick S., Ovemyr J., Blumel J. Occurrence of hepatitis E virus RNA in plasma donations from Sweden, Germany and the United States. Vox Sang 2012, 103:89-90.
54. Ijaz S., Szypulska R., Tettmar K.I., Kitchen A., Tedder R.S. Detection of hepatitis E virus RNA in plasma mini-pools from blood donors in England. Vox Sang 2012, 102:272-410.
55. Said B., Ijaz S., Kafatos G., Booth L., Thomas H.L., Walsh A., et al. Hepatitis E outbreak on cruise ship. Emerg Infect Dis 2009, 15:1738-1744.
56. Fainboim H., Gonzalez J., Fassio E., Martinez A., Otegui L., Eposto M., et al. Prevalence of hepatitis viruses in an anti-human immunodeficiency virus-positive population from Argentina. A multicentre study. J Viral Hepat 1999, 6:53-57.
57. Crum-Cianflone N.F., Curry J., Drobeniuc J., Weintrob A., Landrum M., Ganesan A., et al. Hepatitis E virus infection in HIV-infected persons. Emerg Infect Dis 2012, 18:502-506.
58. van Welzen B.J., Lunel F.M., Meindertsma F., Hoepelman A.I., Arends J.E. Hepatitis E virus as a causative agent of unexplained liver enzyme elevations in HIV-infected patients. J Acquir Immune Defic Syndr 2012, 60:e65-e67.
59. Pischke S., Ho H., Urbanek F., Meyer-Olsen D., Suneetha P.V., Manns M.P., et al. Hepatitis E in HIV-positive patients in a low-endemic country. J Viral Hepat 2010, 17:598-599.
60. Keane F., Gompels M., Bendall R., Drayton R., Jennings L., Black J., et al. Hepatitis E virus coinfection in patients with HIV infection. HIV Med 2012, 13:83-88.
61. Balayan M.S., Fedorova O.E., Mikhailov M.I., Rytick P.G., Eremin V.F., Danilova T.I., et al. Antibody to hepatitis E virus in HIV-infected individuals and AIDS patients. J Viral Hepat 1997, 4:279-283.
62. Naik A., Gupta N., Goel D., Ippagunta S.K., Sharma R.K., Aggarwal R. Lack of evidence of hepatitis E virus infection among renal transplant recipients in a disease-endemic area. J Viral Hepat 2013, 20:e138-e140.
63. Aggarwal R., Naik S. Epidemiology of hepatitis E: current status. J Gastroenterol Hepatol 2009, 24:1484-1493.
64. Mansuy J.M., Huynh A., Abravanel F., Recher C., Peron J.M., Izopet J. Molecular evidence of patient-to-patient transmission of hepatitis E virus in a hematology ward. Clin Infect Dis 2009, 48:373-374.
65. Colson P., Coze C., Gallian P., Henry M., De M.P., Tamalet C. Transfusion-associated hepatitis E, France. Emerg Infect Dis 2007, 13:648-649.
66. Menendez C., Sanchez-Tapias J.M., Kahigwa E., Mshinda H., Costa J., Vidal J., et al. Prevalence and mother-to-infant transmission of hepatitis viruses B, C, and E in Southern Tanzania. J Med Virol 1999, 58:215-220.
67. Siddiqui A.R., Jooma R.A., Smego R.A. Nosocomial outbreak of hepatitis E infection in Pakistan with possible parenteral transmission. Clin Infect Dis 2005, 40:908-909.
68. Clemente-Casares P., Pina S., Buti M., Jardi R., MartIn M., Bofill-Mas S., et al. Hepatitis E virus epidemiology in industrialized countries. Emerg Infect Dis 2003, 9:448-454.
69. Ishida S., Yoshizumi S., Ikeda T., Miyoshi M., Goto A., Matsubayashi K., et al. Detection and molecular characterization of hepatitis E virus in clinical, environmental and putative animal sources. Arch Virol 2012, 157(12):2363-2368.
70. Torresi J., Johnson D. Hepatitis a and e infection in international travellers. Curr Infect Dis Rep 2011, 13:248-255.
71. Colson P., Kaba M., Moreau J., Brouqui P. Hepatitis E in an HIV-infected patient. J Clin Virol 2009, 45:269-271.
72. Dalton H.R., Keane F.E., Bendall R., Mathew J., Ijaz S. Treatment of chronic hepatitis E in a patient with HIV infection. Ann Intern Med 2011, 155:479-480.
73. Kaba M., Richet H., Ravaux I., Moreau J., Poizot-Martin I., Motte A., et al. Hepatitis E virus infection in patients infected with the human immunodeficiency virus. J Med Virol 2011, 83:1704-1716.
74. Kamar N., Garrouste C., Haagsma E.B., Garrigue V., Pischke S., Chauvet C., et al. Factors associated with chronic hepatitis in patients with hepatitis E virus infection who have received solid organ transplants. Gastroenterology 2011, 140:1481-1489.
75. Kamar N., Weclawiak H., Guilbeau-Frugier C., Legrand-Abravanel F., Cointault O., Ribes D., et al. Hepatitis E virus and the kidney in solid-organ transplant patients. Transplantation 2012, 93:617-623.
76. Legrand-Abravanel F., Kamar N., Sandres-Saune K., Garrouste C., Dubois M., Mansuy J.M., et al. Characteristics of autochthonous hepatitis E virus infection in solid-organ transplant recipients in France. J Infect Dis 2010, 202:835-844.
77. Pas S.D., de Man R.A., Mulders C., Balk A.H., van Hal P.T., Weimar W., et al. Hepatitis E virus infection among solid organ transplant recipients, the Netherlands. Emerg Infect Dis 2012, 18:869-872.
78. Peron J.M., Mansuy J.M., Recher C., Bureau C., Poirson H., Alric L., et al. Prolonged hepatitis E in an immunocompromised patient. J Gastroenterol Hepatol 2006, 21:1223-1224.
79. Tavitian S., Peron J.M., Huynh A., Mansuy J.M., Ysebaert L., Huguet F., et al. Hepatitis E virus excretion can be prolonged in patients with hematological malignancies. J Clin Virol 2010, 49:141-144.
80. Dalton H.R., Bendall R.P., Rashid M., Ellis V., Ali R., Ramnarace R., et al. Host risk factors and autochthonous hepatitis E infection. Eur J Gastroenterol Hepatol 2011, 23:1200-1205.
81. Hoerning A., Hegen B., Wingen A.M., Cetiner M., Lainka E., Kathemann S., et al. Prevalence of hepatitis E virus infection in pediatric solid organ transplant recipients-a single-center experience. Pediatr Transplant 2012, 16:742-747.
82. Junge N., Pischke S., Baumann U., Goldschmidt I., Manns M., Wedemeyer H., et al. Results of single-center screening for chronic hepatitis E in children after liver transplantation and report on successful treatment with ribavirin. Pediatr Transplant 2013, 17:343-347.
83. Halac U., Beland K., Lapierre P., Patey N., Ward P., Brassard J., et al. Cirrhosis due to chronic hepatitis E infection in a child post-bone marrow transplant. J Pediatr 2012, 160:871-874.
84. Davern T.J., Chalasani N., Fontana R.J., Hayashi P.H., Protiva P., Kleiner D.E., et al. Acute hepatitis E infection accounts for some cases of suspected drug-induced liver injury. Gastroenterology 2011, 141:1665-1672.
85. Kumar A., Beniwal M., Kar P., Sharma J.B., Murthy N.S. Hepatitis E in pregnancy. Int J Gynaecol Obstet 2004, 85:240-244.
86. Navaneethan U., Al M.M., Shata M.T. Hepatitis E and pregnancy: understanding the pathogenesis. Liver Int 2008, 28:1190-1199.
87. Anty R., Ollier L., Peron J.M., Nicand E., Cannavo I., Bongain A., et al. First case report of an acute genotype 3 hepatitis E infected pregnant woman living in South-Eastern France. J Clin Virol 2012, 54:76-78.
88. Dalton H.R., Hazeldine S., Banks M., Ijaz S., Bendall R. Locally acquired hepatitis E in chronic liver disease. Lancet 2007, 369:1260.
89. Peron J.M., Bureau C., Poirson H., Mansuy J.M., Alric L., Selves J., et al. Fulminant liver failure from acute autochthonous hepatitis E in France: description of seven patients with acute hepatitis E and encephalopathy. J Viral Hepat 2007, 14:298-303.
90. Nanji A.A., French S.W. Relationship between pork consumption and cirrhosis. Lancet 1985, 1:681-683.
91. Dalton H.R., Bendall R.P., Pritchard C., Henley W., Melzer D. National mortality rates from chronic liver disease and consumption of alcohol and pig meat. Epidemiol Infect 2010, 138:174-182.
92. Di B.I., ez-Valcarce M., Vasickova P., Kralik P., Hernandez M., Angeloni G., et al. Hepatitis E virus in pork production chain in Czech Republic, Italy, and Spain, 2010. Emerg Infect Dis 2012, 18:1282-1289.
93. Barnaud E., Rogee S., Garry P., Rose N., Pavio N. Thermal inactivation of infectious hepatitis E virus in experimentally contaminated food. Appl Environ Microbiol 2012, 78:5153-5159.
94. Emerson S.U., Arankalle V.A., Purcell R.H. Thermal stability of hepatitis E virus. J Infect Dis 2005, 192:930-933.
95. Pischke S., Suneetha P.V., Baechlein C., Barg-Hock H., Heim A., Kamar N., et al. Hepatitis E virus infection as a cause of graft hepatitis in liver transplant recipients. Liver Transpl 2010, 16:74-82.
96. Agrawal V., Goel A., Rawat A., Naik S., Aggarwal R. Histological and immunohistochemical features in fatal acute fulminant hepatitis E. Indian J Pathol Microbiol 2012, 55:22-27.
97. Kamar N., Bendall R.P., Peron J.M., Cintas P., Prudhomme L., Mansuy J.M., et al. Hepatitis E virus and neurologic disorders. Emerg Infect Dis 2011, 17:173-179.
98. Sudhamshu K.C., Khadka S., Sharma D., Chataut S.P. Acute pancreatitis in acute viral hepatitis. J Nepal Med Assoc 2011, 51:7-10.
99. Shah S.A., Lal A., Idrees M., Hussain A., Jeet C., Malik F.A., et al. Hepatitis E virus-associated aplastic anaemia: the first case of its kind. J Clin Virol 2012, 54:96-97.
100. Gerolami R., Borentain P., Raissouni F., Motte A., Solas C., Colson P. Treatment of severe acute hepatitis E by ribavirin. J Clin Virol 2011, 52:60-62.
101. Alric L., Bonnet D., Beynes-Rauzy O., Izopet J., Kamar N. Definitive clearance of a chronic hepatitis E virus infection with ribavirin treatment. Am J Gastroenterol 2011, 106:1562-1563.
102. Peron J.M., Dalton H., Izopet J., Kamar N. Acute autochthonous hepatitis E in western patients with underlying chronic liver disease: a role for ribavirinα. J Hepatol 2011, 54:1323-1324.
103. Goyal R., Kumar A., Panda S.K., Paul S.B., Acharya S.K. Ribavirin therapy for hepatitis E virus-induced acute on chronic liver failure: a preliminary report. Antivir Ther 2012, 10.
104. Suneetha P.V., Pischke S., Schlaphoff V., Grabowski J., Fytili P., Gronert A., et al. Hepatitis E virus (HEV)-specific T-cell responses are associated with control of HEV infection. Hepatology 2012, 55:695-708.
105. Chaillon A., Sirinelli A., De M.A., Nicand E., d'Alteroche L., Goudeau A. Sustained virologic response with ribavirin in chronic hepatitis E virus infection in heart transplantation. J Heart Lung Transplant 2011, 30:841-843.
106. Mallet V., Nicand E., Sultanik P., Chakvetadze C., Tesse S., Thervet E., et al. Brief communication: case reports of ribavirin treatment for chronic hepatitis E. Ann Intern Med 2010, 153:85-89.
107. Kamar N., Rostaing L., Abravanel F., Garrouste C., Lhomme S., Esposito L., et al. Ribavirin therapy inhibits viral replication on patients with chronic hepatitis E virus infection. Gastroenterology 2010, 139:1612-1618.
108. Pischke S., Stiefel P., Franz B., Bremer B., Suneetha P.V., Heim A., et al. Chronic hepatitis E in heart transplant recipients. Am J Transplant 2012, 12:3128-3133.
109. Pischke S., Hardtke S., Bode U., Birkner S., Chatzikyrkou C., Kauffmann W., et al. Ribavirin treatment of acute and chronic hepatitis E: a single-centre experience. Liver Int 2013, 33:722-726.
110. Kamar N., Rostaing L., Abravanel F., Garrouste C., Esposito L., Cardeau-Desangles I., et al. Pegylated interferon-alpha for treating chronic hepatitis E virus infection after liver transplantation. Clin Infect Dis 2010, 50:e30-e33.
111. Haagsma E.B., Riezebos-Brilman A., van den Berg A.P., Porte R.J., Niesters H.G. Treatment of chronic hepatitis E in liver transplant recipients with pegylated interferon alpha-2b. Liver Transpl 2010, 16:474-477.
112. Shrestha M.P., Scott R.M., Joshi D.M., Mammen M.P., Thapa G.B., Thapa N., et al. Safety and efficacy of a recombinant hepatitis E vaccine. N Engl J Med 2007, 356:895-903.
113. Zhu F.C., Zhang J., Zhang X.F., Zhou C., Wang Z.Z., Huang S.J., et al. Efficacy and safety of a recombinant hepatitis E vaccine in healthy adults: a large-scale, randomised, double-blind placebo-controlled, phase 3 trial. Lancet 2010, 376:895-902.
114. Neukam K., Barreiro P., Macias J., Avellon A., Cifuentes C., Martin-Carbonero L., et al. Chronic hepatitis E in HIV patients: rapid progression to cirrhosis and response to oral ribavirin. Clin Infect Dis 2013, 57:465-468.